Published January 2021 | Version v1
Journal article

Development and utilization of an infectious clone for porcine deltacoronavirus strain USA/IL/2014/026

  • 1. Department of Microbiology and Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153 (United States)
  • 2. Virus and Prion Research Unit, USDA-ARS-National Animal Disease Center, Ames, IA, 50010 (United States)
  • 3. Animal Disease Research & Diagnostic Laboratory, South Dakota State University, Brookings, SD, 57007 (United States)

Description

Highlights: • Developed a full-length infectious clone for porcine deltacoronavirus USA strain. • The recombinant PDCoV phenocopies the parental strain in vitro and in vivo. • Two mutant viruses were generated to investigate putative interferon antagonists. • Nsp15/EndoU, but not NS6, acts as an interferon antagonist during viral infection. We report the generation of a full-length infectious cDNA clone for porcine deltacoronavirus strain USA/IL/2014/026. Similar to the parental strain, the infectious clone virus (icPDCoV) replicated efficiently in cell culture and caused mild clinical symptoms in piglets. To investigate putative viral interferon (IFN) antagonists, we generated two mutant viruses: a nonstructural protein 15 mutant virus that encodes a catalytically-inactive endoribonuclease (icEnUmut), and an accessory gene NS6-deletion virus in which the NS6 gene was replaced with the mNeonGreen sequence (icDelNS6/nG). By infecting PK1 cells with these recombinant PDCoVs, we found that icDelNS6/nG elicited similar levels of type I IFN responses as icPDCoV, however icEnUmut stimulated robust type I IFN responses, demonstrating that the deltacoronavirus endoribonuclease, but not NS6, functions as an IFN antagonist in PK1 cells. Collectively, the construction of a full-length infectious clone and the identification of an IFN-antagonistic endoribonuclease will aid in the development of live-attenuated deltacoronavirus vaccines.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.virol.2020.11.002

Additional details

Identifiers

DOI
10.1016/j.virol.2020.11.002;
PII
S0042682220302245;

Publishing Information

Journal Title
Virology (New York, N.Y. Print)
Journal Volume
553
Journal Page Range
p. 35-45
ISSN
0042-6822
CODEN
VIRLAX

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54004272
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CELL CULTURES; GENES; IN VITRO; IN VIVO; INTERFERON; MUTANTS; PATHOGENESIS; SYMPTOMS; VACCINES; VIRUSES
Descriptors DEC
GROWTH FACTORS; LYMPHOKINES; MICROORGANISMS; MITOGENS; ORGANIC COMPOUNDS; PARASITES; PROTEINS

Optional Information

Copyright
Copyright (c) 2020 Elsevier Inc.